GT Biopharma, Inc.

New Filing
CIK: 0000109657·Biotechnology·DELAWARE·Filed: May 27, 2025
Total Offering

$5,950,000

Amount Sold

$5,950,000

Investors

9

First Sale

May 12, 2025

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Michael Breen
Related Person
Alan Urban
Related Person
Charles Casamento
Related Person
Hilary Kramer
Related Person
Andrew Ritter
Related Person

Company

GT Biopharma, Inc.

505 MONTGOMERY STREET

SAN FRANCISCO, CA, 94111

800-304-9888

SEC Filing

0001641172-25-012480

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free